All News #Library
Biotech
Astellas and Kate Therapeutics Announce Exclusive License Agreement for KT430
08 Jun 2023 //
PR NEWSWIRE
Kate Therapeutics Debuts With $51 Million Series A to Develop Genetic Medicines
08 Jun 2023 //
PR NEWSWIRE

Market Place
Sourcing Support